Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 1 of 1 for:    NCT02201459
Previous Study | Return to List | Next Study

Nilotinib ± Peg-IFN for First Line Chronic Phase CML Patients (PETALs)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02201459
Recruitment Status : Unknown
Verified August 2014 by Hospices Civils de Lyon.
Recruitment status was:  Recruiting
First Posted : July 28, 2014
Last Update Posted : August 7, 2014
Information provided by (Responsible Party):
Hospices Civils de Lyon

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : January 2018
Estimated Study Completion Date : August 2019